Read + Share
Janssen YF, Feitsma EA, Boersma HH, Alleva DG, et al. Phase I interim results of a phase I/II study of the IgG-Fc fusion COVID-19
subunit vaccine, AKS-452. Vaccine 2022 Jan 31. pii: S0264-410X(22)00077.
PMID: 35115195
|
 |
|
Janssen YF, Feitsma EA, Boersma HH, Alleva DG, et al. Phase I interim results of a phase I/II study of the IgG-Fc fusion COVID-19
subunit vaccine, AKS-452. Vaccine 2022 Jan 31. pii: S0264-410X(22)00077.
PMID: 35115195
|
|
|
|